Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX

Abstract

Developing a broadly protective vaccine covering most ETEC variants has been elusive. The most clinically advanced candidate yet is an oral inactivated ETEC vaccine (ETVAX

Description

Keywords

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By